NPT Texxon Holding Ltd Annual reports only
Wholesale-Chemicals & Allied Products · Nasdaq · SEC CIK 2014337 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-39.3%
TTM net income YoY-420.6%
TTM EPS YoY-360.0%
Revenue 3-yr CAGR-4.3%
Net income 3-yr CAGR—
Margins
Gross margin0.2%
Operating margin-1.7%
Net margin-1.0%
FCF margin-2.7%
EBITDA margin-1.3%
Returns
ROE-176.4%
ROA-3.2%
ROIC (approx.)-16.6%
Asset turnover3.18x
Leverage & solvency
Liabilities / assets65.1%
Debt / equity4.51x
Current ratio0.45x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.36x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $484.04M | $797.15M | $672.66M | $552.53M |
| Cost of revenue | $482.94M | $792.45M | $667.85M | $548.99M |
| Gross profit | $1.10M | $4.70M | $4.82M | $3.53M |
| SG&A expense | $7.35M | $2.89M | $2.17M | $1.28M |
| Operating income | -$8.08M | -$600,646 | $659,969 | $1.25M |
| Pretax income | -$8.99M | -$737,235 | $3.23M | $2.13M |
| Income tax | $0 | $716,897 | $716,782 | $42,998 |
| Net income | -$4.86M | -$932,621 | $953,560 | $2.02M |
| EBITDA | -$6.45M | -$312,574 | $992,697 | $1.51M |
| EPS (basic) | -0.23 | -0.05 | 0.05 | 0.10 |
| EPS (diluted) | -0.23 | -0.05 | 0.05 | 0.10 |
| Weighted avg. shares (diluted) | 21.50M | 20.00M | 20.00M | 20.00M |
| Balance sheet | ||||
| Cash & equivalents | $94,101 | $2.52M | $272,895 | $12.18M |
| Receivables | $1.10M | $7.52M | $11.09M | — |
| Inventory | $2.01M | $973,644 | $667.61M | $548.79M |
| Current assets | $35.06M | $20.76M | $18.05M | — |
| PP&E, net | $121.11M | $84.62M | $23.36M | — |
| Intangibles | $6.79M | $6.16M | $6.21M | — |
| Total assets | $165.24M | $138.97M | $89.70M | $74.91M |
| Current liabilities | $77.79M | $72.74M | $57.32M | — |
| Short-term debt | $12.26M | $0 | $25.79M | — |
| Long-term debt | $29.75M | $32.18M | $25.79M | — |
| Total debt | $42.02M | $32.18M | $51.58M | — |
| Total liabilities | $107.60M | $104.92M | $57.32M | — |
| Shareholders' equity | $9.32M | -$3.81M | -$2.85M | $33.08M |
| Net debt | $41.92M | $29.66M | $51.30M | — |
| Shares outstanding | 22.18M | 20.00M | 20.00M | — |
| Cash flow statement | ||||
| Operating cash flow | $1.76M | $2.32M | -$30.80M | -$14.18M |
| Capital expenditure | $14.77M | $45.10M | $33.34M | $22.62M |
| Free cash flow | -$13.01M | -$42.78M | -$64.13M | -$36.80M |
| Investing cash flow | -$15.03M | -$42.25M | -$11.02M | -$41.23M |
| Financing cash flow | $10.39M | $41.36M | $29.36M | $30.41M |
| Depreciation & amortization | $1.63M | $288,072 | $332,728 | $251,081 |
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.